Stay updated on Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 is displayed, replacing v3.4.1; no study content, endpoints, or navigation were altered.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page now displays Revision: v3.4.1 instead of v3.4.0. All study content, links, and instructions appear unchanged.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a consolidated Locations section listing Florida, Iowa, Minnesota, Nebraska, Oregon, and Pennsylvania. Updated the revision to v3.3.3 and removed the prior separate location sections (Florida Locations, Iowa Locations, Minnesota Locations, Nebraska Locations, Oregon Locations, Pennsylvania Locations) along with the HHS Vulnerability Disclosure link.SummaryDifference0.7%

- Check85 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.3.1 has been removed.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded revision v3.3.1 and removed revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.